Chromatin-Spliceosome Mutations in Acute Myeloid Leukemia
Recent genetic studies on large patient cohorts with acute myeloid leukemia (AML) have cataloged a comprehensive list of driver mutations, resulting in the classification of AML into distinct genomic subgroups. Among these subgroups, chromatin-spliceosome (CS)-AML is characterized by mutations in th...
Main Authors: | Yotaro Ochi, Seishi Ogawa |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/6/1232 |
Similar Items
-
Long Non-coding RNAs as Functional and Structural Chromatin Modulators in Acute Myeloid Leukemia
by: Alexander A. Wurm, et al.
Published: (2019-09-01) -
Therapy related acute myeloid leukemia with t(10:16): a rare entity
by: Guldeep K. Uppal, et al.
Published: (2011-12-01) -
Epigenetic Therapies for Acute Myeloid Leukemia and Their Immune-Related Effects
by: Valentina Gambacorta, et al.
Published: (2019-10-01) -
Hypomethylating Chemotherapeutic Agents as Therapy for Myelodysplastic Syndromes and Prevention of Acute Myeloid Leukemia
by: Vincent G. Sorrentino, et al.
Published: (2021-07-01) -
Epigenetics in a Spectrum of Myeloid Diseases and Its Exploitation for Therapy
by: Michael Maher, et al.
Published: (2021-04-01)